Medicare Part D plans are putting an increasing proportion of generics on non-preferred tiers, according to a new analysis by Avalere, but the report does not identify the proportion of brands that plans are preferring over generics, so it’s impossible to determine the extent to which plans are giving favorable formulary placement to brands facing generic competition. Since 2016, the percentage of generics on preferred and generic formulary tiers has dropped from 65% to 43%, Avalere reports. Beneficiaries pay less...